This study examined real-world prescribing patterns of antipsychotic medications in nearly 60,000 patients across eight diagnostic groups with psychotic features, including schizophrenia, schizoaffective disorder, psychotic bipolar disorder, psychotic depression, delusional disorders, acute transient psychosis, organic delusional disorder, and substance-induced psychosis.
The authors suggest that patients with schizoaffective disorder might benefit from greater use of LAIs and clozapine, and that treatment approaches for psychotic depression may not be making full use of LAI options. They recommend further research on the comparative effectiveness of antipsychotics across these diagnostic groups.
For more details, you can access the full article here.
Recent Posts
- Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder
- The Rise of AI Companions and What it Means for Youth Mental Health
- The Neuropsychiatry Brief — Edition 18 Circuit Psychiatry: TMS, theta burst, accelerated protocols, and why the delivery system may be the treatment